AU4343796A - Tachykinin antagonists - Google Patents
Tachykinin antagonistsInfo
- Publication number
- AU4343796A AU4343796A AU43437/96A AU4343796A AU4343796A AU 4343796 A AU4343796 A AU 4343796A AU 43437/96 A AU43437/96 A AU 43437/96A AU 4343796 A AU4343796 A AU 4343796A AU 4343796 A AU4343796 A AU 4343796A
- Authority
- AU
- Australia
- Prior art keywords
- tachykinin antagonists
- tachykinin
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9425085.9A GB9425085D0 (en) | 1994-12-13 | 1994-12-13 | Organic compounds |
| GB9425085 | 1994-12-13 | ||
| GBGB9426016.3A GB9426016D0 (en) | 1994-12-22 | 1994-12-22 | Organic compounds |
| GB9426016 | 1994-12-22 | ||
| PCT/EP1995/004910 WO1996018643A1 (en) | 1994-12-13 | 1995-12-12 | Tachykinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4343796A true AU4343796A (en) | 1996-07-03 |
Family
ID=26306161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU43437/96A Abandoned AU4343796A (en) | 1994-12-13 | 1995-12-12 | Tachykinin antagonists |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0797583A1 (en) |
| JP (1) | JPH10511935A (en) |
| AR (1) | AR001332A1 (en) |
| AU (1) | AU4343796A (en) |
| BR (1) | BR9509997A (en) |
| CA (1) | CA2204130A1 (en) |
| CO (1) | CO4700289A1 (en) |
| CZ (1) | CZ179097A3 (en) |
| FI (1) | FI971685A (en) |
| HU (1) | HUT77002A (en) |
| IL (1) | IL116323A0 (en) |
| NO (1) | NO972526D0 (en) |
| PE (1) | PE38997A1 (en) |
| PL (1) | PL320217A1 (en) |
| SK (1) | SK74697A3 (en) |
| TR (1) | TR199501568A2 (en) |
| WO (1) | WO1996018643A1 (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6117855A (en) | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| EP0929303B1 (en) * | 1996-10-07 | 2006-07-26 | Merck Sharp & Dohme Ltd. | Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agent |
| WO2000048623A1 (en) | 1999-02-18 | 2000-08-24 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| NZ552397A (en) | 2004-07-15 | 2011-04-29 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| WO2006123182A2 (en) | 2005-05-17 | 2006-11-23 | Merck Sharp & Dohme Limited | Cyclohexyl sulphones for treatment of cancer |
| EP1904069B1 (en) | 2005-07-15 | 2018-06-13 | Albany Molecular Research, Inc. | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| BRPI0616463A2 (en) | 2005-09-29 | 2011-06-21 | Merck & Co Inc | compound, pharmaceutical composition, and use of a compound |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| WO2008039327A2 (en) | 2006-09-22 | 2008-04-03 | Merck & Co., Inc. | Method of treatment using fatty acid synthesis inhibitors |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| AU2008204380B2 (en) | 2007-01-10 | 2013-08-15 | Msd Italia S.R.L. | Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors |
| JP2010516734A (en) | 2007-01-24 | 2010-05-20 | グラクソ グループ リミテッド | 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine or R (-)-2,4-diamino-5- (2,3-dichlorophenyl) -6-fluoromethylpyrimidine A pharmaceutical composition comprising |
| EP2145884B1 (en) | 2007-04-02 | 2014-08-06 | Msd K.K. | Indoledione derivative |
| US8389553B2 (en) | 2007-06-27 | 2013-03-05 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| JP2011515343A (en) | 2008-03-03 | 2011-05-19 | タイガー ファーマテック | Tyrosine kinase inhibitor |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| EP2413932A4 (en) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | Inhibitors of akt activity |
| KR20120034644A (en) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| KR20120023072A (en) | 2009-05-12 | 2012-03-12 | 브리스톨-마이어스 스큅 컴퍼니 | Crystalline forms of (s)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorohphenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| NZ596104A (en) | 2009-05-12 | 2014-01-31 | Albany Molecular Res Inc | 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof |
| BR112012008849A2 (en) | 2009-10-14 | 2015-09-22 | Schering Corp | compound, pharmaceutical composition, and use of a compound |
| EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
| JP6043285B2 (en) | 2010-08-02 | 2016-12-14 | サーナ・セラピューティクス・インコーポレイテッドＳｉｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | RNA interference-mediated inhibition of catenin (cadherin-binding protein) β1 (CTNNB1) gene expression using small interfering nucleic acids (siNA) |
| HUE044815T2 (en) | 2010-08-17 | 2019-11-28 | Sirna Therapeutics Inc | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| EP2613782B1 (en) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
| WO2012036997A1 (en) | 2010-09-16 | 2012-03-22 | Schering Corporation | Fused pyrazole derivatives as novel erk inhibitors |
| US9260471B2 (en) | 2010-10-29 | 2016-02-16 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) |
| WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| US20140045847A1 (en) | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
| WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| EP3919620A1 (en) | 2012-05-02 | 2021-12-08 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
| US9233979B2 (en) | 2012-09-28 | 2016-01-12 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
| BR112015012295A8 (en) | 2012-11-28 | 2023-03-14 | Merck Sharp & Dohme | USE OF A WEE1 INHIBITOR, E, KIT TO IDENTIFY A PATIENT WITH CANCER |
| BR112015013611A2 (en) | 2012-12-20 | 2017-11-14 | Merck Sharp & Dohme | compound and pharmaceutical composition |
| EP2951180B1 (en) | 2013-01-30 | 2018-05-02 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3833667B1 (en) | 2018-08-07 | 2024-03-13 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
| WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164372A (en) * | 1989-04-28 | 1992-11-17 | Fujisawa Pharmaceutical Company, Ltd. | Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same |
| JPH05186498A (en) * | 1991-12-27 | 1993-07-27 | Japan Tobacco Inc | Proline derivative |
-
1995
- 1995-12-11 IL IL11632395A patent/IL116323A0/en unknown
- 1995-12-11 PE PE1995286859A patent/PE38997A1/en not_active Application Discontinuation
- 1995-12-12 PL PL95320217A patent/PL320217A1/en unknown
- 1995-12-12 CA CA002204130A patent/CA2204130A1/en not_active Abandoned
- 1995-12-12 WO PCT/EP1995/004910 patent/WO1996018643A1/en not_active Application Discontinuation
- 1995-12-12 HU HU9701897A patent/HUT77002A/en unknown
- 1995-12-12 SK SK746-97A patent/SK74697A3/en unknown
- 1995-12-12 AU AU43437/96A patent/AU4343796A/en not_active Abandoned
- 1995-12-12 EP EP95942131A patent/EP0797583A1/en not_active Withdrawn
- 1995-12-12 CO CO95058767A patent/CO4700289A1/en unknown
- 1995-12-12 BR BR9509997A patent/BR9509997A/en not_active Application Discontinuation
- 1995-12-12 CZ CZ971790A patent/CZ179097A3/en unknown
- 1995-12-12 JP JP8518261A patent/JPH10511935A/en active Pending
- 1995-12-13 TR TR95/01568A patent/TR199501568A2/en unknown
- 1995-12-13 AR AR33458995A patent/AR001332A1/en unknown
-
1997
- 1997-04-18 FI FI971685A patent/FI971685A/en not_active Application Discontinuation
- 1997-06-03 NO NO972526A patent/NO972526D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9703957A (en) | 1997-09-30 |
| NO972526L (en) | 1997-06-03 |
| CA2204130A1 (en) | 1996-06-20 |
| WO1996018643A1 (en) | 1996-06-20 |
| JPH10511935A (en) | 1998-11-17 |
| HUT77002A (en) | 1998-03-02 |
| NO972526D0 (en) | 1997-06-03 |
| FI971685A0 (en) | 1997-04-18 |
| EP0797583A1 (en) | 1997-10-01 |
| SK74697A3 (en) | 1997-11-05 |
| PL320217A1 (en) | 1997-09-15 |
| IL116323A0 (en) | 1996-03-31 |
| CZ179097A3 (en) | 1997-10-15 |
| BR9509997A (en) | 1997-12-30 |
| CO4700289A1 (en) | 1998-12-29 |
| FI971685A (en) | 1997-08-13 |
| TR199501568A2 (en) | 1996-07-21 |
| AR001332A1 (en) | 1997-10-22 |
| PE38997A1 (en) | 1997-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1842995A (en) | N-acylpiperidine tachykinin antagonists | |
| AU4343796A (en) | Tachykinin antagonists | |
| AU1273195A (en) | Tachykinin antagonists | |
| AU5342894A (en) | Tachykinin antagonists | |
| AU2524995A (en) | Neurokinine (tachykinine) antagonists | |
| AU5333596A (en) | 3-benzylamino-2-phenylpiperidines as neurokinin antagonists | |
| AU1765695A (en) | Non-peptidyl tachykinin receptor antagonists | |
| AU5603094A (en) | N,n-diacylpiperazine tachykinin antagonists | |
| AU5440996A (en) | 2-acylaminopropanamides as tachykinin receptor antagonists | |
| AU3899997A (en) | Muscarinic antagonists | |
| AU2143295A (en) | Neurokinin receptor antagonists | |
| AU7947594A (en) | Substituted amides as tachykinin antagonists | |
| AU4036895A (en) | Substituted 1H-imidazoles | |
| AU3567195A (en) | Neurokinin antagonists | |
| HU9601176D0 (en) | Adhesion-receptor antagonists | |
| AU1872697A (en) | Toothbrush | |
| AU6856796A (en) | Des-arg9-bk antagonists | |
| AU3397195A (en) | Construction elements | |
| NZ324712A (en) | 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists | |
| AU2844595A (en) | Substituted biphenyloxazolines | |
| AU3002695A (en) | Ige antagonists | |
| HU9503191D0 (en) | Adhesion-receptor antagonists | |
| AU5764298A (en) | Tachykinin antagonists | |
| AU1574995A (en) | Tachykinins antagonists | |
| AU2320895A (en) | Polyalkylpiperidine compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |